Characteristics of adults seeking medical marijuana certification

Drug and Alcohol Dependence

Volumn 132, Issue 3, 2013, Pages 654-659

  Ilgen, Mark A ^a,b   Bohnert, Kipling ^a,b   Kleinberg, Felicia ^a,b   Jannausch, Mary ^a,b   Bohnert, Amy S B ^a,b   Walton, Maureen ^a,b   Blow, Frederic C ^a,b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Chronic pain; Drug dependence; Health services; Marijuana

Indexed keywords

AMPHETAMINE; CANNABIS; COCAINE; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADULT; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; DRUG UTILIZATION; FEMALE; HEALTH CARE ACCESS; HEALTH CARE NEED; HEALTH VISITOR; HELP SEEKING BEHAVIOR; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PAIN; PATIENT ATTITUDE; PHYSICAL PERFORMANCE; PRESCRIPTION; PRIORITY JOURNAL; WAITING ROOM;

CANNABIS SATIVA;

CHRONIC PAIN; DRUG DEPENDENCE; HEALTH SERVICES; MARIJUANA;

ADOLESCENT; ADULT; CERTIFICATION; DATA COLLECTION; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; MEDICAL MARIJUANA; MIDDLE AGED; PAIN MANAGEMENT; YOUNG ADULT;

EID: 84883558941     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.04.019     Document Type: Article

References (38)

1. Adefuye A., Abiona T., Balogun J., Lukobo-Durrell M. HIV sexual risk behaviors and perception of risk among college students: implications for planning interventions. BMC Public Health 2009, 9:281.
2. Aggarwal, S.K., Carter, G.T., Sullivan, M.D., ZumBrunnen, C., Morrill, R., Mayer, J.D. Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington state reveals managed chronic illness and debility. Am. J. Hosp. Palliat. Care, , in press. http://www.ncbi.nlm.nih.gov/pubmed/22887696.
3. Babor T.F., De La Fuente J.R., Saunders J., Grant M. AUDIT-the Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care 1989, World Health Organization, Geneva.
4. Brodbeck J., Matter M., Moggi F. Association between cannabis use and sexual risk behavior among young heterosexual adults. AIDS Behav. 2006, 10:599-605.
5. Brook J.S., Stimmel M.A., Zhang C., Brook D.W. The association between earlier marijuana use and subsequent academic achievement and health problems: a longitudinal study. Am. J. Addict. 2008, 17:155-160.
6. Buckner J.D., Heimberg R.G., Schmidt N.B. Social anxiety and marijuana-related problems: the role of social avoidance. Addict. Behav. 2011, 36:129-132.
7. Butler S.F., Budman S.H., Fernandez K.C., Houle B., Benoit C., Katz N., Jamison R.N. Development and validation of the current opioid misuse measure. Pain 2007, 130:144-156.
8. Campbell F.A., Tramer M.R., Carroll D., Reynolds D.J., Moore R.A., McQuay H.J. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001, 323:13-16.
9. Conigrave K.M., Hall W.D., Saunders J.B. The AUDIT questionnaire: choosing a cut-off score. Alcohol use disorder identification test. Addiction 1995, 90:1349-1356.
10. D'Souza D.C. Cannabinoids and psychosis. Int. Rev. Neurobiol. 2007, 78:289-326.
11. Farrar J.T., Young J.P., LaMoreaux L., Werth J.L., Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001, 94:149-158.
12. Fussman, C., 2012. Prevalence Estimates for Risk Factors and Health Indicators; Michigan Behavioral Risk Factor Survey 2011. Michigan Department of Community Health.
13. Gruber A.J., Pope H.G., Hudson J.I., Yurgelun-Todd D. Attributes of long-term heavy cannabis users: a case-control study. Psychol. Med. 2003, 33:1415-1422.
14. Holdcroft A., Smith M., Jacklin A., Hodgson H., Smith B., Newton M., Evans F. Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia 1997, 52:483-486.
15. Institute of Medicine, 1999. Marijuana and Medicine: Assessing the Science Base. http://wwwnapedu/openbookphp%3Frecord_id=6376%26page=8.
16. Institute of Medicine, 2009. Use of Cannabis for Medicinal Purposes. Report 3 of the Council on Science and Public Health (I-09).
17. Jochimsen P.R., Lawton R.L., VerSteeg K., Noyes R. Effect of benzopyranoperidine, a delta-9-THC congener, on pain. Clin. Pharmacol. Ther. 1978, 24:223-227.
18. Kandel D.B., Yamaguchi K., Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J. Stud. Alcohol 1992, 53:447-457.
19. Kleber H.D., Dupont R.L. Physicians and medical marijuana. Am. J. Psychiatry 2012, 169:564-568.
20. Maurer M., Henn V., Dittrich A.A.H. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur. Arch. Psychiatry Clin. Neurosci. 1990, 240:1-4.
21. Moore B.A., Augustson E.M., Moser R.P., Budney A.J. Respiratory effects of marijuana and tobacco use in a U.S. sample. J. Gen. Intern. Med. 2005, 20:33-37.
22. Naar-King S., Kolmodin K., Parsons J.T., Murphy D. Psychosocial factors and substance use in high-risk youth living with HIV: a multi-site study. AIDS Care 2010, 22:475-482.
23. Narang S., Gibson D., Wasan A.D., Ross E.L., Michna E., Nedeljkovic S.S., Jamison R.N. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J. Pain 2008, 9:254-264.
24. Noyes R., Brunk S.F., Baram D.A., Canter A. Analgesic effect of delta-9-tetrahydrocannabinol. J. Clin. Pharmacol. 1975, 15:139-143.
25. Reinert D., Allen J. The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol. Clin. Exp. Res. 2002, 26:272-279.
26. Stack P., Suddath C. A Brief History of Medical Marijuana. Time Magazine 2009.
27. Staquet M., Gantt C., Machin D. Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. Clin. Pharmacol. Ther. 1978, 23:397-401.
28. Stinson F.S., Ruan W.J., Pickering R., Grant B.F. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol. Med. 2006, 36:1447-1460.
29. Substance Abuse and Mental Health Services Administration, 2010. Results from the 2009 National Survey on Drug Use and Health: National findings. Office of Applied Studies, Rockville, MD.
30. Substance Abuse and Mental Health Services Administration, 2011. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. In: Substance Abuse and Mental Health Services Administration (Ed.). N.S.D.U.H. Series H-41, H.H.S. Publication No. 11-4658, Rockville, MD.
31. The Associated Press, November 14, 2010. Arizona Becomes 15th State to Approve Medical Marijuana. The New York Times,. http://www.nytimes.com/2010/11/15/us/politics/15arizona.html.
32. Wagner F.A., Anthony J.C. Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am. J. Epidemiol. 2002, 155:918-925.
33. Ware J.E., Kosinski M., Keller S.D. S.F.-12: How to Score the S.F.-12 Physical and Mental Health Summary Scales 1995, The Health Institute, Boston, MA.
34. Ware J.E., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Care 1996, 34:220-233.
35. Ware M., Doyle C., Woods R., Lynch M., Clark A. Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain 2003, 102:211-216.
36. Ware M.A., Adams H., Guy G.W. The medicinal use of cannabis in the UK: results of a nationwide survey. Int. J. Clin. Pract. 2005, 59:291-295.
37. WHO ASSIST Working Group, 2002. The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST): development reliability and feasibility. Addiction 97, 1183-1194.
38. Wilsey B., Marcotte T., Tsodikov A., Millman J., Bentley H., Gouaux B., Fishman S. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J. Pain 2008, 9:506-521.